• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Addex Therapeutics Ltd

+ Add to Watchlist


1.627 EUR 0.064 4.09%

As of 11:21:46 ET on 04/17/2014.

Snapshot for Addex Therapeutics Ltd (APE)

Open: 1.561 Day's Range: 1.529 - 1.630 Volume: 0
Previous Close: 1.563 52wk Range: 1.490 - 5.853 1-Yr Rtn: -70.90%

Stock Chart for APE

No chart data available.
  • APE:GR 1.627
  • 1D
  • 1M
  • 1Y
Interactive APE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for APE

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. DAX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2013) -1.8450
Est. PEG Ratio -
Market Cap (M EUR) 16.55
Shares Outstanding (M) 10.17
30 Day Average Volume 138
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for APE

No data available

Company Profile & Key Executives for APE

Addex Therapeutics Ltd is a biotechnology company. The Company discovers and develops a type of orally available small molecule drugs, called allosteric modulators, to treat a broad range of diseases.

Andre J MuellerNon Exec Chair/Interim CEO/Interim PresGraham DixonChief Scientific Ofcr/Head:Rsch
Sonia PoliHead:Non-Clinical Development
More Company Profile & Key Executives for APE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil